Erratum to: BMC Genomics doi:10.1186/1471-2164-15-S7-S2
Following the publication of our recent article in BMC Genomics [1] we wish to acknowledge the contribution to the concept for our study provided by the previous work of Papillon-Cavanagh et al. [2] and note that we should have included a reference to their paper in the legend to Figure 1. Furthermore when discussing our findings that NQO1 is a marker for sensitivity of TNBC to 17-AAG we should have cited Papillon-Cavanagh et al. [2] as a previous paper where similar results were reported. We apologize to all affected parties.
Footnotes
The online version of the original article can be found under doi:10.1186/1471-2164-15-S7-S2.
Contributor Information
Lindsay C Stetson, Email: jsb42@case.edu.
Taylor Pearl, Email: jsb42@case.edu.
Yanwen Chen, Email: jsb42@case.edu.
Jill S Barnholtz-Sloan, Email: jsb42@case.edu.
References
- 1.Stetson LC, Pearl T, Chen Y, Sloan JS B. Computational identification of multi-omic correlates of anticancer therapeutic response. BMC Genomics. 2014;15(Suppl 7):S2. doi: 10.1186/1471-2164-15-S7-S2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Papillon-Cavanagh S, De Jay N, Hachem N, Olsen C, Bontempi G, Aerts HJ, et al. Comparison and validation of genomic predictors for anticancer drug sensitivity. Journal of the American Medical Informatics Association: JAMIA. 2013;20(4):597–602. doi: 10.1136/amiajnl-2012-001442. [DOI] [PMC free article] [PubMed] [Google Scholar]